Histamine receptor antagonists, cyclooxygenase blockade, and tumor necrosis factor during acute septic insult.
Tumor necrosis factor (TNF) may be a major endogenous mediator of sepsis-induced acute organ injury. We proposed that treatment of septic pigs with the combined agents ibuprofen, a cyclooxygenase inhibitor, and histamine receptor antagonists, cimetidine (H2 antagonist) and diphenhydramine (H1 antagonist) would result in lower circulating levels of TNF and decreased parameters of sepsis-induced injury in these animals. To test this, plasma TNF activity, cardiac index, systemic and pulmonary arterial pressures, arterial PO2 and bronchoalveolar lavage protein content were monitored for 300 min in four groups of anesthetized pigs: saline-infused control pigs (n = 4); pigs infused for 60 min with Pseudomonas aeruginosa (5 x 10(8) organisms/mL, .3 mL/20 kg/min) (n = 5) and pigs infused for 60 min with P. aeruginosa plus ibuprofen (12.5 mg/kg) alone (n = 4) or ibuprofen plus cimetidine (150 mg) and diphenhydramine (30 mg/kg) at 0 and 120 min (CID, n = 4). Within 60 min, pigs infused with P. aeruginosa exhibited increased plasma TNF activity (>8-fold increase in ng/mL TNF; L929 cytolysis assay) and showed alterations in all hemodynamic and pulmonary parameters. Ibuprofen or CID administration in the septic pigs decreased peak TNF activity by 4.6 and 10.2 ng/mL, respectively, and CID treatment was correlated with better attenuation of certain sepsis-induced alterations. These results show that CID treatment attenuates sepsis-induced injury and that this is correlated with reduced plasma TNF activity in a porcine model of sepsis-induced acute organ injury.
Leeper-Woodford
S K
SK
Department of Medicine, Virginia Commonwealth University/Medical College of Virginia, Richmond, USA.
Carey
D
D
Byrne
K
K
Walsh
C
C
Fisher
B
B
Sugerman
H J
HJ
Fowler
A A
AA
D000818:Animals; D016470:Bacteremia / Q000188:drug therapy* / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002927:Cimetidine / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004155:Diphenhydramine / Q000494:pharmacology; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006633:Histamine Antagonists / Q000494:pharmacology*; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007052:Ibuprofen / Q000494:pharmacology; D011552:Pseudomonas Infections / Q000188:drug therapy; D013552:Swine; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000378:metabolism*
D016861:Cyclooxygenase Inhibitors; D006633:Histamine Antagonists; D014409:Tumor Necrosis Factor-alpha; D002927:Cimetidine; D004155:Diphenhydramine; D007052:Ibuprofen